Anthony “Nino” Sireci, MD, MSc, senior vice president, clinical biomarker and diagnostics development, at Eli Lilly and Company,
Navigating the Alzheimer Disease Blood Test Revolution
A new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.